-
Sanofi
- Medical Writer
Paris
2014 - maintenant
Global Medical Affairs and Consumer healthcare departments
* Provide scientific and medical support to the Medical experts: monitor worldwide literature on
International databases and internal databases/ analysis of publications and guidelines
relevant to the products of the portfolio (OTC drugs, anti-inflammatory drugs, antibiotics,
gastroenterology medications, vitamins and food supplements, cardiology drugs...)
* Regulatory and medical writing: marketing authorization renewals/ registration and periodic
benefit risk assessments: ``Addendum to clinical overview'' (ACO) and Clinical Expert
Statements (CES), ``clinical overview'' (CTD Module 2.5), clinical summary (CTD Module2.7)
periodic benefit risk evaluation reports (PBRER), summary of clinical pharmacology, pediatric
clinical overviews (EU-article 45 pediatric regulation), answer letters to health authorities
questions
* Scientific writing for marketing purposes: scientific brochure, abstracts...
* Coordination and collaboration with different clinicians/medical experts and interaction with
regulatory/publishing departments
* Management of the planning/ coordination of the medical writing activity
* Deep knowledge of European and international regulations (EMEA, ICH)
-
Lincoln
- Medical Writer, Sanofi -Mandated by LINCOLN
Boulogne-Billancourt
2014 - maintenant
-
Nidcom
- Chargé de missions: rédaction scientifique et médicale
2013 - 2013
-
Nidcom
- Medical writer
2013 - 2013
* Collaboration with scientific and medical writing agencies
* Literature review/ publications analysis/ managing literature with Endnote
* Writing of a non-clinical overview (CTD module 2.4) for marketing authorizations in Europe
* Writing of a scientific article, in dermatology field, for submission to a peer-reviewed journal
-
Aureus Sciences
- Analyste scientifique des essais cliniques
2011 - 2012
-
Aureus Sciences
- Scientific analyst
2011 - 2012
* Provide the scientific support to develop a database for clinical trials for Immuno-
Inflammatory diseases
* Scientific data analysis: Literature monitoring/ Analysis of publications and synthesis of
data/Use of bibliographic management software (reference manager/ endnote)
* Information and Knowledge Management: Designing a database for clinical data; data entry
in the database, defining entry rules, create medical dictionaries and glossaries...
* Scientific writing: writing documents and deliverables for European scientific projects
(Biointelligence)/ Designing and writing of scientific posters for international conferences
* Collaboration with pharmaceutical industries/ meetings with experts/ attend national and
international conferences
* Provide support to the team on clinical research aspects and methodology/Training
colleagues on the basic principles of clinical research
-
Louis Mourier Hospital
- CRA training
2011 - 2011
(AP-HP) (Department of internal medicine)
Clinical research associate Training, 3 months,
* Phase III clinical studies in thromboembolic diseases: patient screening, randomization, CRF
filling, responding to queries, patient's visits (planning, sampling kits, treatments...),
archiving documentation, reporting adverse effects
* contribution in writing clinical study reports/ Protocol amendments requests
* Phase IV clinical studies : International database for thromboembolic diseases (RIETE)
-
APHP-Hôpital Louis Mourier
- Stage Recherche clinique
2011 - 2011
De février à avril 2011: stage en recherche clinique. Screening de patients elligibles, planning des visites de patients, saisie de données dans les CRFS, gestion des documents de travail de l'essai clinique (fiche de compliance des patients, dossier d'adjudication..)
-
Inserm
- Chercheur contractuel
PARIS 13
2009 - 2009
CDD 6 mois. Département hématologie, Institut Cochin.
-
INSERM
- Research engineer
PARIS 13
2009 - 2009
* Obtaining knockout mouse lines / Cell Culture / phenotyping and cell sorting
* Writing protocols and scientific documents and presentations
* Use of technical illustration software (ImageJ, canvas...)
-
Institut Pasteur- Université Pierre et Marie Curie
- Biologiste Doctorant
2003 - 2008
Potentiel vaccinal des protéines de la famille MSP3 de Plasmodium falciparum: évaluation de différentes constructions de MSP3-1, de quatre nouveaux membres de la famille de protéines MSP3, et d’une première construction multigénique